Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 5 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Prevalence of MGCS Among Patients With Monoclonal Gammopathies.
Hemasphere. 2023 May 31;7(6):e908. doi: 10.1097/HS9.0000000000000908. eCollection 2023 Jun.
Hemasphere. 2023.
PMID: 37275739
Free PMC article.
No abstract available.
Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era.
Ntanasis-Stathopoulos I, Filippatos C, Gavriatopoulou M, Malandrakis P, Eleutherakis-Papaiakovou E, Spiliopoulou V, Syrigou RE, Theodorakakou F, Fotiou D, Migkou M, Roussou M, Kastritis E, Dimopoulos MA, Terpos E.
Ntanasis-Stathopoulos I, et al. Among authors: spiliopoulou v.
Diseases. 2023 Sep 18;11(3):123. doi: 10.3390/diseases11030123.
Diseases. 2023.
PMID: 37754319
Free PMC article.
Item in Clipboard
Management and Outcomes of Anti-CD38 Refractory Patients: The Impact of Retreatment and of Subsequent Therapies.
Kastritis E, Theodorakakou F, Ntanasis-Stathopoulos I, Spiliopoulou V, Solia E, Malandrakis P, Syrigou R, Kokkali N, Migkou M, Eleutherakis-Papaiakovou E, Fotiou D, Roussou M, Kanellias N, Gavriatopoulou M, Terpos E, Dimopoulos MA.
Kastritis E, et al. Among authors: spiliopoulou v.
Hemasphere. 2023 Nov 3;7(11):e975. doi: 10.1097/HS9.0000000000000975. eCollection 2023 Nov.
Hemasphere. 2023.
PMID: 37936678
Free PMC article.
No abstract available.
Item in Clipboard
Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study.
Spiliopoulou V, Ntanasis-Stathopoulos I, Malandrakis P, Gavriatopoulou M, Theodorakakou F, Fotiou D, Migkou M, Roussou M, Eleutherakis-Papaiakovou E, Kastritis E, Dimopoulos MA, Terpos E.
Spiliopoulou V, et al.
Viruses. 2023 Mar 8;15(3):704. doi: 10.3390/v15030704.
Viruses. 2023.
PMID: 36992413
Free PMC article.
Item in Clipboard
Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma.
Ntanasis-Stathopoulos I, Malandrakis P, Fotiou D, Migkou M, Theodorakakou F, Roussou M, Eleutherakis-Papaiakovou E, Spiliopoulou V, Kastritis E, Terpos E, Dimopoulos MA, Gavriatopoulou M.
Ntanasis-Stathopoulos I, et al. Among authors: spiliopoulou v.
Int J Mol Sci. 2023 Jul 23;24(14):11829. doi: 10.3390/ijms241411829.
Int J Mol Sci. 2023.
PMID: 37511588
Free PMC article.
Item in Clipboard
Characteristics and Outcomes of Patients With Relapsed/Refractory Multiple Myeloma After Exposure to Lenalidomide in First Line of Therapy: A Single Center Database Review in Greece.
Kastritis E, Ntanasis-Stathopoulos I, Theodorakakou F, Migkou M, Roussou M, Malandrakis P, Kanellias N, Eleutherakis-Papaiakovou E, Fotiou D, Spiliopoulou V, Gavriatopoulou M, Patel S, Majer I, Boukis C, Fetani A, Dimopoulos MA, Terpos E.
Kastritis E, et al. Among authors: spiliopoulou v.
Clin Lymphoma Myeloma Leuk. 2024 Mar 19:S2152-2650(24)00110-1. doi: 10.1016/j.clml.2024.03.003. Online ahead of print.
Clin Lymphoma Myeloma Leuk. 2024.
PMID: 38616479
Free article.
Item in Clipboard
Cite
Cite